See more news releases in: Publishing & Information Services, Health Care & Hospitals, Surveys, Polls and Research, Clinical Trials & Medical Discoveries
Reportlinker Adds Diabetic Neuropathy Global Clinical Trials Review, Q2, 2011
NEW YORK, June 9, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
Diabetic Neuropathy Global Clinical Trials Review, Q2, 2011
Diabetic Neuropathy Global Clinical Trials Review, Q2, 2011
Summary
GlobalData's clinical trial report, "Diabetic Neuropathy Global Clinical Trials Review, Q1, 2011" provides data on the Diabetic Neuropathy clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Diabetic Neuropathy. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Diabetic Neuropathy. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)
Reasons to buy
- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 6
Introduction 7
Diabetic Neuropathy 7
Report Guidance 7
Clinical Trials by Region 8
Clinical Trials by Country 9
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 12
Top Five Countries Contributing to Clinical Trials in Europe 13
Top Countries Contributing to Clinical Trials in North America 14
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 15
Top Five Countries Contributing to Clinical Trials in Central and South America 16
Clinical Trials by BRIC Nations 17
Clinical Trials by Phase 18
In Progress Trials by Phase 19
Clinical Trials by Trial Status 20
Unaccomplished Trials of Diabetic Neuropathy 21
Subjects Recruited Over a Period of Time 25
Prominent Sponsors 26
Top Companies Participating in Diabetic Neuropathy Therapeutics Clinical Trials 28
Prominent Drug Comparison 30
Clinical Trial Profiles 31
Clinical Trial Overview of Top Companies 31
Pfizer Inc. 31
Clinical Trial Overview of Pfizer Inc. 31
Eli Lilly and Company 33
Clinical Trial Overview of Eli Lilly and Company 33
Johnson & Johnson 34
Clinical Trial Overview of Johnson & Johnson 34
UCB S.A. 35
Clinical Trial Overview of UCB S.A. 35
Sangamo BioSciences, Inc. 36
Clinical Trial Overview of Sangamo BioSciences, Inc. 36
Novartis AG 37
Clinical Trial Overview of Novartis AG 37
Grunenthal GmbH 38
Clinical Trial Overview of Grunenthal GmbH 38
UCB, Inc. 39
Clinical Trial Overview of UCB, Inc. 39
Takeda Pharmaceutical Company Limited 40
Clinical Trial Overview of Takeda Pharmaceutical Company Limited 40
Abbott Laboratories 41
Clinical Trial Overview of Abbott Laboratories 41
Dainippon Sumitomo Pharma Co., Ltd. 42
Clinical Trial Overview of Dainippon Sumitomo Pharma Co., Ltd. 42
Merck & Co., Inc. 43
Clinical Trial Overview of Merck & Co., Inc. 43
Meda AB 44
Clinical Trial Overview of Meda AB 44
EpiCept Corporation 45
Clinical Trial Overview of EpiCept Corporation 45
NeurogesX, Inc. 46
Clinical Trial Overview of NeurogesX, Inc. 46
Eisai Inc. 47
Clinical Trial Overview of Eisai Inc. 47
Takeda Global Research and Development Center, Inc 48
Clinical Trial Overview of Takeda Global Research and Development Center, Inc 48
Bial - Portela & Ca, S.A. 49
Clinical Trial Overview of Bial - Portela & Ca, S.A. 49
Endo Pharmaceuticals Inc. 50
Clinical Trial Overview of Endo Pharmaceuticals Inc. 50
Mitsubishi Tanabe Pharma Corporation 51
Clinical Trial Overview of Mitsubishi Tanabe Pharma Corporation 51
Clinical Trial Overview of Top Universities / Institutes / Hospitals 52
U.S. Department of Veterans Affairs 52
Clinical Trial Overview of U.S. Department of Veterans Affairs 52
Maastricht University Medical Center 53
Clinical Trial Overview of Maastricht University Medical Center 53
University of Michigan 54
Clinical Trial Overview of University of Michigan 54
The University of Kansas 55
Clinical Trial Overview of The University of Kansas 55
Hospital Universitario "Dr. Jose E. Gonzalez" 56
Clinical Trial Overview of Hospital Universitario "Dr. Jose E. Gonzalez" 56
Weill Cornell Medical College 57
Clinical Trial Overview of Weill Cornell Medical College 57
Oregon Health and Science University 58
Clinical Trial Overview of Oregon Health and Science University 58
Stanford University 59
Clinical Trial Overview of Stanford University 59
Johann Wolfgang Goethe University Hospitals 60
Clinical Trial Overview of Johann Wolfgang Goethe University Hospitals 60
Scott & White 61
Clinical Trial Overview of Scott & White 61
Eastern Virginia Medical School 62
Clinical Trial Overview of Eastern Virginia Medical School 62
University of Duisburg-Essen 63
Clinical Trial Overview of University of Duisburg-Essen 63
The University of Texas Southwestern Medical Center at Dallas 64
Clinical Trial Overview of The University of Texas Southwestern Medical Center at Dallas 64
Fundacao Amparo a Pesquisa do Estado Sao Paulo 65
Clinical Trial Overview of Fundacao Amparo a Pesquisa do Estado Sao Paulo 65
Southern California Institute for Research and Education 66
Clinical Trial Overview of Southern California Institute for Research and Education 66
Shiraz University of Medical Sciences 67
Clinical Trial Overview of Shiraz University of Medical Sciences 67
University Hospital, Bordeaux 68
Clinical Trial Overview of University Hospital, Bordeaux 68
Duke University 69
Clinical Trial Overview of Duke University 69
Rosalind Franklin University of Medicine and Science 70
Clinical Trial Overview of Rosalind Franklin University of Medicine and Science 70
Washington State University 71
Clinical Trial Overview of Washington State University 71
Appendix 72
Abbreviations 72
Definitions 72
Research Methodology 73
Secondary Research 73
About GlobalData 74
Contact Us 74
Disclaimer 74
Source 74
List of Tables
Diabetic Neuropathy Therapeutics Market, Global, Clinical Trials by Zone, 2011* 8
Diabetic Neuropathy Therapeutics Market, Global, Clinical Trials by Top Countries, 2011* 10
Diabetic Neuropathy Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2011* 11
Diabetic Neuropathy Therapeutics Clinical Trials, Asia-Pacific , Top Five Countries, 2011* 12
Diabetic Neuropathy Therapeutics Clinical Trials, Europe, Top Five Countries, 2011* 13
Diabetic Neuropathy Therapeutics Clinical Trials, North America, Top Countries, 2011* 14
Diabetic Neuropathy Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2011* 15
Diabetic Neuropathy Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2011* 16
Diabetic Neuropathy Therapeutics Clinical Trials, BRIC Countries, 2011* 17
Diabetic Neuropathy Therapeutics Market, Global, Clinical Trials by Phase, 2011* 18
Diabetic Neuropathy Therapeutics Market, Global, Clinical Trials In Progress by Phase 2011* 19
Diabetic Neuropathy Therapeutics Market, Global, Clinical Trials by Trial Status, 2011* 20
Diabetic Neuropathy Therapeutics Market, Global, Suspended Clinical Trials, 2011* 21
Diabetic Neuropathy Therapeutics Market, Global, Withdrawn Clinical Trials, 2011* 22
Diabetic Neuropathy Therapeutics Market, Global, Terminated Clinical Trials, 2011* 23
Diabetic Neuropathy Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010 25
Diabetic Neuropathy Therapeutics Clinical Trials, Global, Key Sponsors, 2011* 27
Diabetic Neuropathy Therapeutics Clinical Trials, Global, Top Companies by Phase, 2011* 29
Diabetic Neuropathy Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2011* 30
Diabetic Neuropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2011* 31
Diabetic Neuropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Eli Lilly and Company, 2011* 33
Diabetic Neuropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Johnson & Johnson, 2011* 34
Diabetic Neuropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by UCB S.A., 2011* 35
Diabetic Neuropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Sangamo BioSciences, Inc., 2011* 36
Diabetic Neuropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2011* 37
Diabetic Neuropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Grunenthal GmbH, 2011* 38
Diabetic Neuropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by UCB, Inc., 2011* 39
Diabetic Neuropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Takeda Pharmaceutical Company Limited, 2011* 40
Diabetic Neuropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Abbott Laboratories, 2011* 41
Diabetic Neuropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Dainippon Sumitomo Pharma Co., Ltd., 2011* 42
Diabetic Neuropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2011* 43
Diabetic Neuropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Meda AB, 2011* 44
Diabetic Neuropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by EpiCept Corporation, 2011* 45
Diabetic Neuropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by NeurogesX, Inc., 2011* 46
Diabetic Neuropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Eisai Inc., 2011* 47
Diabetic Neuropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Takeda Global Research and Development Center, Inc, 2011* 48
Diabetic Neuropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Bial - Portela & Ca, S.A., 2011* 49
Diabetic Neuropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Endo Pharmaceuticals Inc., 2011* 50
Diabetic Neuropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Mitsubishi Tanabe Pharma Corporation, 2011* 51
Diabetic Neuropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by U.S. Department of Veterans Affairs, 2011* 52
Diabetic Neuropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Maastricht University Medical Center, 2011* 53
Diabetic Neuropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Michigan, 2011* 54
Diabetic Neuropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Kansas, 2011* 55
Diabetic Neuropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Hospital Universitario "Dr. Jose E. Gonzalez", 2011* 56
Diabetic Neuropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Weill Cornell Medical College, 2011* 57
Diabetic Neuropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Oregon Health and Science University, 2011* 58
Diabetic Neuropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Stanford University, 2011* 59
Diabetic Neuropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Johann Wolfgang Goethe University Hospitals, 2011* 60
Diabetic Neuropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Scott & White, 2011* 61
Diabetic Neuropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Eastern Virginia Medical School, 2011* 62
Diabetic Neuropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Duisburg-Essen, 2011* 63
Diabetic Neuropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Texas Southwestern Medical Center at Dallas, 2011* 64
Diabetic Neuropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Fundacao Amparo a Pesquisa do Estado Sao Paulo, 2011* 65
Diabetic Neuropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Southern California Institute for Research and Education, 2011* 66
Diabetic Neuropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Shiraz University of Medical Sciences, 2011* 67
Diabetic Neuropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospital, Bordeaux, 2011* 68
Diabetic Neuropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Duke University, 2011* 69
Diabetic Neuropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Rosalind Franklin University of Medicine and Science, 2011* 70
Diabetic Neuropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Washington State University, 2011* 71
List of Figures
Diabetic Neuropathy Therapeutics Market, Global, Clinical Trials by Zone (%), 2011* 8
Diabetic Neuropathy Therapeutics Market, Global, Clinical Trials by Top Countries, 2011* 9
Diabetic Neuropathy Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2011* 11
Diabetic Neuropathy Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2011* 12
Diabetic Neuropathy Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2011* 13
Diabetic Neuropathy Therapeutics Clinical Trials, North America, Top Countries (%), 2011* 14
Diabetic Neuropathy Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2011* 15
Diabetic Neuropathy Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2011* 16
Diabetic Neuropathy Therapeutics Clinical Trials, BRIC Countries (%), 2011* 17
Diabetic Neuropathy Therapeutics Market, Global, Clinical Trials by Phase (%), 2011* 18
Diabetic Neuropathy Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2011* 19
Diabetic Neuropathy Therapeutics Market, Global, Clinical Trials by Trial Status, 2011* 20
Diabetic Neuropathy Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010 25
Diabetic Neuropathy Therapeutics Clinical Trials, Global, Key Sponsors, 2011* 26
Diabetic Neuropathy Therapeutics Clinical Trials, Global, Top Companies by Phase, 2011* 28
Diabetic Neuropathy Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2011* 30
GlobalData Methodology 73
To order this report:
Drug Discovery and Development Industry: Diabetic Neuropathy Global Clinical Trials Review, Q2, 2011
Drug Discovery and Development Business News
Check our Company Profile, SWOT and Revenue Analysis!
CONTACT:
Nicolas Bombourg
Reportlinker
Email: nbo@reportlinker.com
US: +1-805-652-2626
Intl: +1-805-652-2626
SOURCE Reportlinker
Back to top
RELATED LINKS
http://www.reportlinker.com
Custom Packages
Browse our custom packages or build your own to meet your unique communications needs.
PR Newswire Membership
Fill out a PR Newswire membership form or contact us at (888) 776-0942.
Learn about PR Newswire services
Request more information about PR Newswire products and services or call us at (888) 776-0942.
Featured Video
More in These Categories
Journalists and Bloggers
Visit PR Newswire for Journalists for releases, photos, ProfNet experts, and customized feeds just for Media.
View and download archived video content distributed by MultiVu on The Digital Center.
Free Investing Newsletter from Investor Uprising!
Learn to navigate the world's financial system and profit from leading companies.
Register for Investor Uprising, the people's investment site, for a free weekly newsletter, information, education and premium research including our latest IU Confidential Report - "All That Glitters: The Ultimate Gold Report".